Heart Disease News and Research

Latest Heart Disease News and Research

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners.

8 Jan 2010

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.

8 Jan 2010

Abiomed announces preliminary third quarter fiscal 2010 revenue

Abiomed, Inc., a leading provider of breakthrough heart support technologies designed for heart recovery, today announced preliminary third quarter fiscal 2010 revenue of approximately $22.8 million, up 32% compared to revenue of $17.3 million for the same period of fiscal 2009.

8 Jan 2010

Young men with HIV infection have coronary atherosclerotic plaques: MGH study

A Massachusetts General Hospital (MGH) study has found that relatively young men with longstanding HIV infection and minimal cardiac risk factors had significantly more coronary atherosclerotic plaques - some involving serious arterial blockage - than did uninfected men with similar cardiovascular risk.

8 Jan 2010

Nation's best cardiac programs team up to offer improved heart care

Mount Sinai Medical Center in Miami Beach is among Florida's most renowned heart hospitals. New York's Columbia University Medical Center is ranked among the nation's top cardiovascular programs. Together, they take the best heart care and make it better for South Florida

8 Jan 2010

University Hospitals Case Medical Center conducts Phase 2 clinical trial of gene therapy for AD

University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer's disease (AD). The study uses a viral-based gene transfer system called CERE-110, which is designed to deliver nerve growth factor (NGF) into the brain.

8 Jan 2010

Genzyme enters into mutual cooperation agreement with Relational Investors

Genzyme Corporation and San-Diego based institutional investor Relational Investors LLC announced today that they have entered into a mutual cooperation agreement. Relational, a $6 billion private investment fund, began investing in Genzyme shares in late 2008 and currently owns approximately 4 percent of the company’s common stock.

8 Jan 2010

Final health care reform legislation requires comprehensive coverage of smoking cessation treatment

As Congress negotiates a final health care reform bill, lawmakers should seize this unprecedented opportunity to invest in proven measures that prevent costly diseases from occurring in the first place, which will improve health and reduce health care costs. These include measures to prevent and reduce tobacco use, which remains the leading cause of preventable death in the United States, killing more than 400,000 people and costing the nation $96 billion in health care expenditures annually.

8 Jan 2010

Boar's Head launches campaign to encourage salt sensible food choices

Recognizing that salt consumption has long been a concern in matters of health, Boar's Head, one of the nation's leading manufacturers of deli meats and cheeses, reaffirms its commitment to wellness with a campaign that encourages salt sensible food choices. "Launch Your Assault on Salt," offers consumers who have concerns about their salt intake with advice about food options that fit their needs and shows them how, when managed wisely, it can be part of a healthy diet.

8 Jan 2010

LSUHSC receives $2.1 million grant for pneumonia research

Dr. Jay Kolls, Professor and Chairman of Genetics at the LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $2.1 million grant over five years by the National Heart, Lung, and Blood Institute of the National Institutes of Health to further his work on a discovery that plays a critical role in the body's defense against pneumonia.

8 Jan 2010

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

Reata Pharmaceuticals, Inc. (Reata) and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) announced today that they have entered into a licensing agreement that provides Kyowa Hakko Kirin with the exclusive rights to develop and commercialize Reata’s lead compound, bardoxolone methyl (bardoxolone), in Japan and other selected Asian markets.

8 Jan 2010

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

A new study has shown that metformin, a drug often used in the treatment of diabetes mellitus, is safe for use in treating patients who have both diabetes and advanced heart failure.

7 Jan 2010

New cardiac procedure may reduce complications and hospital costs

A new approach to common cardiac procedures called transradial angiography might lead to reduced patient complications and recovery time and decreased hospital costs.

7 Jan 2010

Carolinas MED-1 to house a clinic for residents to get H1N1 Flu shots

Carolinas MED-1 - the first mobile hospital of its kind in the world - will be serving the people of Charlotte and Mecklenburg County when it is deployed this Saturday for an H1N1 vaccine clinic.

7 Jan 2010

High or low blood calcium levels linked to increased risk of premature death in kidney disease patients

Abnormally high or low blood calcium levels are linked to an increased chance of premature death in non-dialysis kidney disease patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

7 Jan 2010

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.

7 Jan 2010

Heart Force Medical closes its private, non-brokered financing after raising $4.8 million net

Heart Force Medical Inc., a Vancouver-based company that is developing a non-invasive cardiac assessment, monitoring and screening device, announces today that it has closed its private, non-brokered financing after raising $4.8 million net.

7 Jan 2010

Minnesota dentists to provide free dental care to less fortunate children

Minnesota dentists will provide free dental care to less fortunate children on Friday, February 5 and Saturday, February 6 at nearly 200 locations statewide. The Minnesota Dental Association is sponsoring this unique outreach effort, called Give Kids a Smile, for the 8th consecutive year. Appointments are being scheduled now.

7 Jan 2010

BUSM researchers develop mathematical methodology to reduce biologic variation in clinical status

Clinicians rely on laboratory tests to monitor the progression or remission of disease, or to identify pathologic alterations in physiology that may precede clinical events. Monitoring quantitative laboratory results represents a crucial component in the assessment of response to therapy.

7 Jan 2010

Educational sessions and special workshops highlight advancements in molecular imaging

SNM's Conjoint Mid-Winter Meetings, Jan. 27-Feb. 2, 2010, in Albuquerque, N.M., will bring together four scientific meetings under one umbrella. The meeting, which provides attendees with the opportunity to earn up to 25 continuing education credits, will highlight the latest advancements in molecular imaging and nuclear medicine. The educational sessions will conclude with special workshops on nanomedicine and clinical trials.

7 Jan 2010

Heart Disease News and Research

Latest Heart Disease News and Research

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Abiomed announces preliminary third quarter fiscal 2010 revenue

Young men with HIV infection have coronary atherosclerotic plaques: MGH study

Nation's best cardiac programs team up to offer improved heart care

University Hospitals Case Medical Center conducts Phase 2 clinical trial of gene therapy for AD

Genzyme enters into mutual cooperation agreement with Relational Investors

Final health care reform legislation requires comprehensive coverage of smoking cessation treatment

Boar's Head launches campaign to encourage salt sensible food choices

LSUHSC receives $2.1 million grant for pneumonia research

Kyowa Hakko Kirin receives exclusive rights to develop and commercialize bardoxolone methyl

UCLA: Metformin can be used to treat patients with diabetes and advanced heart failure

New cardiac procedure may reduce complications and hospital costs

Carolinas MED-1 to house a clinic for residents to get H1N1 Flu shots

High or low blood calcium levels linked to increased risk of premature death in kidney disease patients

Positive results from phase 2 study evaluating the safety and efficacy of Qnexa announced

Heart Force Medical closes its private, non-brokered financing after raising $4.8 million net

Minnesota dentists to provide free dental care to less fortunate children

BUSM researchers develop mathematical methodology to reduce biologic variation in clinical status

Educational sessions and special workshops highlight advancements in molecular imaging

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in